Standard Biotools | FLDM - Assets


Standard Biotools reported $539.64M in Assets for its fiscal quarter ending in September of 2025.





Assets Change Date
Agilent USD 12.73B 501M Sep/2025
Becton, Dickinson and Co. USD 54.84B 484M Dec/2025
Bio-Rad Laboratories USD 10.58B 880.1M Dec/2025
Bruker USD 6.24B 193.5M Dec/2025
Danaher USD 83.46B 3.57B Dec/2025
Illumina USD 6.64B 467M Dec/2025
Myriad Genetics USD 728.1M 50.8M Sep/2025
Nikon Corporation JPY 1.1T 54.38B Dec/2025
Pacific Biosciences Of California USD 803.16M 22.31M Sep/2025
Revvity USD 12.17B 29.46M Dec/2025
Roche Holding CHF 100.7B 5.94B Dec/2025
Sony JPY 15.88T 20.24T Dec/2025
Standard Biotools USD 539.64M 17.32M Sep/2025
Thermo Fisher Scientific USD 110.34B 7.32B Dec/2025
Waters USD 5.08B 221.41M Dec/2025